<DOC>
	<DOC>NCT00095810</DOC>
	<brief_summary>The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.</brief_summary>
	<brief_title>Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Primary diagnosis of idiopathic Parkinson's disease. Psychosis related to Parkinson's disease. Psychosis present prior to diagnosis of Parkinson's disease.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Psychosis, Parkinson's Disease</keyword>
</DOC>